Monday, June 15, 2026

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Kim Ha Seong Joins Rays for Two Years, $29 Million After Free Agency Delay

Kim Ha Seong signs a two-year, $29 million contract with the Tampa Bay Rays, marking a significant investment for the team.

Kim Jong Un Pushes ‘Health Revolution’ With New Hospital Projects Across North Korea

Kim Jong Un inspects hospital construction sites, urging advanced methods and a skilled workforce to enhance North Korea's health system.

Tag: Dupixent

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.